MEGHAN DOTTERER: Open Payments
NPI 1053048298 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 90 payments from 16 companies in 2025. Trend: 2023 $2,313 · 2024 $2,683 · 2025 $1,674
Food & beverage: $1,651Education: $23
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $379 |
| Novo Nordisk Inc | 12 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $160 |
| Corcept Therapeutics | 11 | $152 |
| Currax Pharmaceuticals LLC | 13 | $149 |
| Lilly USA, LLC | 7 | $144 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| Exact Sciences Corporation | 5 | $82 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
Products named: FARXIGA, JARDIANCE, Korlym, CONTRAVE, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
